Over the past years J&J stood up several manufacturing plants for cell-therapy. Our teams designed and implemented the supporting manufacturing technologies such as Manufacturing Execution Systems & Laboratory systems at a very high pace atypical for the industry. This is the more remarkable as advanced therapies are still an emerging field with continuous industry learnings.

The presentation is intended to share our learnings from the MES implementation journey. In this session, you will learn more about:

• How J&J accelerated MES implementation to enable rapid scale-up in cell-therapy manufacturing.
• Key challenges faced in an emerging field and the lessons learned along the way.
• The role of fast-paced technology adoption in shaping future best practices for advanced therapies.